A company that develops novel drugs and is committed to innovating therapies and drugs in anaesthesia, pain management, intensive care and neuromodulation.
investor of
Metrics
marketPRIVATE
msh_idCOM:SINTETICA
websitehttps://sintetica.com/
source_reff7ba653e-3237-4e39-a3bb-8a1b3738e67e
products_or_servicesTherapies and drugs in anaesthesia, pain management, intensive care, and neuromodulation